Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

163 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

NCT00520494

Conditions
Agammaglobulinemia, Blood Protein Disorders, Bruton type agammaglobulinemia, +10 more
Locations
  • Contact CSL Behring for facility details Edmonton, Alberta, Canada
  • Contact CSL Behring for facility details Montreal, Quebec, Canada
  • Contact CSL Behring for facility details Leipzig, Germany
  • Contact CSL Behring for facility details Brescia, Italy
View Trial Details
Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

NCT00680446

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Women's & Children's Hospital North Adelaide, South Australia, Australia
View Trial Details
Completed

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

NCT01458171

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Fukuoka, Japan
  • Study site Gifu, Gifu Pref., Japan
View Trial Details
Completed

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

NCT00419341

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study Site Los Angeles, California, United States
  • Study Site Los Angeles, California, United States
  • Study Site Centennial, Colorado, United States
  • Study Site North Palm Beach, Florida, United States
View all 13 locations
View Trial Details
Completed

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

NCT00278954

Conditions
Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +26 more
Locations
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Family Allergy and Asthma Center PC Atlanta, Georgia, United States
  • Rush University Medical Centre, University Consultants in Allergy & Immunology Chicago, Illinois, United States
  • Childrens Hospital at Buffalo, Allergy Division Buffalo, New York, United States
View Trial Details
Completed

Subcutaneous Ig NextGen 16% in PID Patients

NCT00391131

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • The Canberra Hospital Garran, Australian Capital Territory, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View Trial Details
Completed

Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

NCT00405184

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Flinders Medical Centre Adelaide, South Australia, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • The Royal Melbourne Hospital Melbourne, Victoria, Australia
View Trial Details
Completed

Retrospective Chart Review of Subcutaneous IgG Use in Infants

NCT01166074

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Midwest Immunology Clinic Plymouth, Minnesota, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
View Trial Details

Related conditions